*  Search Results - Ethambutol AND subject for consumers medrev[sb] - National Library of Medicine - PubMed Health
Tuberculosis (TB) is an important health problem, especially in developing countries. The treatment for pulmonary TB in new patients includes four oral medicines taken for six months, sometimes as fixed‐dose combinations (FDCs) that are combined in one tablet, or taken separately as single‐drug formulations. The World Health Organization recommends prescribers use fixed‐dose combinations to reduce the number of tablets that people take. On the supply side, this might reduce prescribing errors and improve drug supply efficiency; on the patient's side, FDCS simplify treatment and improve adherence. Cochrane Database of Systematic Reviews: Plain Language Summaries [Internet] - John Wiley & Sons, Ltd.. ...
https://www.ncbi.nlm.nih.gov/pubmedhealth/?term=Ethambutol%20AND%20subject_for_consumers_medrev%5Bsb%5D
*  Infections in Patients with Cancer - Holland-Frei Cancer Medicine - NCBI Bookshelf
Ward T T, Rimland D, Kauffman C. Randomized, open-label trial of azithromycin plus ethambutol vs clarithromycin plus ethambutol ... Treatment with isoniazid, rifampin, ethambutol, and pyrazinamide three times a week for a period of 6 months is also effective. ... Commonly used agents include ethambutol, rifabutin, clarithromycin, azithromycin, and streptomycin.72,73 Refractory cases may ... Cure rates of 90% can be achieved by using regimens containing isoniazid, rifampin, pyrazinamide, and ethambutol or ...
https://www.ncbi.nlm.nih.gov/books/NBK20904/